Abstract:Leber's hereditary optic neuropathy (LHON) is the most common hereditary optic atrophies. The disease causes the bilateral loss of central vision. The importance of LHON lies in it ability to cause such severe and usually permanent vision loss in young adults who are about to start or have recently begun employrent or higher education, and the ramification of diagnosing an inherited disease to other members of the patient's family. The maternal transmission of visual dysfunction in families with LHON suggested the mutations in mitochondrial DNA (mtDNA) are the molecular bases of this disorder. Up to date, 35 LHON-associated mtDNA mutations have been identified in many pedigrees worldwide. Of these, three primary mutations: ND1 G3460A, ND4 G11778A and ND6 T14484C, which involve genes encoding the subunits of respiratory chain complex I, aocounts for more than 50% of LHON pedigrees in different ethnic origins. In particular,the G11778A mutation is the most common LHON-associated mtDNA mutation. Strikingly, matrilineal relatives within families or among families carrying the same LHON-associated mtDNA mutations exhibited variable penetrance and expressivity including the severity, age-of-onset and progression in vision loss. Incomplete and variable penetrance of vision loss as well as mild biochemical defects associated with these mtDNA mutations indicated that the LHON-associated mtDNA mutation(s) itself is not sufficient to produce the clinical phenotype. Therefore, other modifier factors including environmental factors, nuclear modifier genes and mitochondrial haplotypes are required for the phenotypic expression of vision loss associated with these mtDNA mutations, Most eye diseases are tmulti-factorial in etiology. These diseases are caused by complex and interactive effects of personal factors, environmental conditions and gene aberrations. Some of these disorders are known to have a genetic etiology or predisposition with autosomal dominant, autosomal recessive, X-linked or maternally-transmitted pattern of inheritance. Recently, these have rapidly been defined at the molecular levels. In some cases, the maternal transmission of visual dysfunctions suggested the mitochondrial involvement. In fact, mtDNA mutations fiequently manifest with neuro-ophthalmoligcal symptoms. Of these,acute-onset and bilateral optic atrophy is the primary clinical sign of LHON, which is caused by missense mutations in mtDNA[1 -15]. Key words: Leber's hereditary opitc neuropathy; mitochondrial DNA; pathogenetic

Progress of Pelizaeus-Merzbacher Disease

The Clinical Features in Patients with Charcot-Marie-Tooth with PMP22 Duplication

[Clinical and Genetic Analysis of a Family with Pelizaeus-Merzbacher Disease].

Genetic Spectrum of MCM3AP and Its Relationship with Phenotype of Charcot‐Marie‐Tooth Disease

MRI Findings of Pelizaeus-Merzbacher Disease Correlated with Phenotypes and Genetic Mutation

Molecular Pathogenetic Mechanism of Leber's Hereditary Optic Neuropathy

Identification and Functional Study of Novel PLP1 Mutations in Chinese Patients with Pelizaeus–Merzbacher Disease

The magnetic resonance imaging spectrum of Pelizaeus-Merzbacher disease: A multicenter study of 19 patients

[Clinical and Mutation Analysis of a Chinese Family with Muscle Eye Brain Disease].

Clinical and molecular genetic analysis of three pedigrees with Pelizaeus-Merzbacher-like disease

Genotype–phenotype Correlation and Natural History Analyses in a Chinese Cohort with Pelizaeus–merzbacher Disease

Gene Mutation and Clinical Analysis in Machado-Joseph Disease

Pelizaeus–Merzbacher disease: on the cusp of myelin medicine

Proteolipid Protein 1 Gene Mutation in Nine Patients with Pelizaeus-Merzbacher Disease

Moyamoya Disease Presenting As Thalamic Infarction in a Patient with Neuromyelitis Optica Spectrum Disorder

Study on proteolipid protein 1 gene mutation in a Chinese pedigree with Pelizaeus-Merzbacher disease

Clinical, Pathological and Molecular Biological Characteristics of Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episode in Children

Gene Mutations and Prenatal Diagnosis in Six Pedigrees with Pelizaeus-Merzbacher Disease

Case report: A double pathogenic mutation in a patient with late-onset MELAS/PEO overlap syndrome

Novel POMGnT1 Mutations Cause Muscle-Eye-brain Disease in Chinese Patients

Novel Insight into the Potential Pathogenicity of Mitochondrial Dysfunction Resulting from PLP1 Duplication Mutations in Patients with Pelizaeus–Merzbacher Disease